Activation of the rapidly accelerated fibrosarcoma–mitogen-activated protein kinase kinase and phosphatidylinositol 3-kinase signaling pathways further upregulates COX-2 expression in tumor cells (83, 84). The gene discussed is WNK2; the disease is neoplasm.